CN1132582C - 高含量泛西洛维片剂 - Google Patents

高含量泛西洛维片剂 Download PDF

Info

Publication number
CN1132582C
CN1132582C CN97191703A CN97191703A CN1132582C CN 1132582 C CN1132582 C CN 1132582C CN 97191703 A CN97191703 A CN 97191703A CN 97191703 A CN97191703 A CN 97191703A CN 1132582 C CN1132582 C CN 1132582C
Authority
CN
China
Prior art keywords
tablet
famciclovir
graininess
medicinal
excipient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN97191703A
Other languages
English (en)
Chinese (zh)
Other versions
CN1208350A (zh
Inventor
迈克尔·J·格林韦
珍妮弗·M·斯莱特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis International Pharmaceutical Ltd
Original Assignee
Novartis International Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis International Pharmaceutical Ltd filed Critical Novartis International Pharmaceutical Ltd
Publication of CN1208350A publication Critical patent/CN1208350A/zh
Application granted granted Critical
Publication of CN1132582C publication Critical patent/CN1132582C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN97191703A 1996-01-16 1997-01-13 高含量泛西洛维片剂 Expired - Lifetime CN1132582C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9600847.9A GB9600847D0 (en) 1996-01-16 1996-01-16 Pharmaceuticals
GB9600847.9 1996-01-16

Publications (2)

Publication Number Publication Date
CN1208350A CN1208350A (zh) 1999-02-17
CN1132582C true CN1132582C (zh) 2003-12-31

Family

ID=10787105

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97191703A Expired - Lifetime CN1132582C (zh) 1996-01-16 1997-01-13 高含量泛西洛维片剂

Country Status (38)

Country Link
US (1) US6765007B1 (no)
EP (1) EP0874632B1 (no)
JP (2) JP4711360B2 (no)
KR (1) KR100338829B1 (no)
CN (1) CN1132582C (no)
AP (2) AP747A (no)
AR (1) AR005456A1 (no)
AT (1) ATE220910T1 (no)
AU (1) AU713090B2 (no)
BG (1) BG63488B1 (no)
BR (1) BR9706982A (no)
CY (1) CY2390B1 (no)
CZ (1) CZ287205B6 (no)
DE (1) DE69714215T2 (no)
DK (1) DK0874632T3 (no)
DZ (1) DZ2159A1 (no)
EA (1) EA001946B1 (no)
EG (1) EG23684A (no)
ES (1) ES2180922T3 (no)
GB (1) GB9600847D0 (no)
HK (1) HK1016473A1 (no)
HU (1) HU225472B1 (no)
IL (1) IL124913A0 (no)
MX (1) MX9805713A (no)
MY (1) MY127527A (no)
NO (1) NO315689B1 (no)
NZ (1) NZ326769A (no)
OA (1) OA10812A (no)
PE (1) PE35498A1 (no)
PL (1) PL187291B1 (no)
PT (1) PT874632E (no)
SK (1) SK282132B6 (no)
TR (1) TR199800954T2 (no)
TW (1) TW434016B (no)
UA (1) UA63897C2 (no)
UY (2) UY24437A1 (no)
WO (1) WO1997025990A1 (no)
ZA (1) ZA97310B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
ES2401008T3 (es) 2009-06-26 2013-04-16 Taris Biomedical, Inc. Comprimidos farmacéuticos sólidos para dispositivos implantables para la administración de fármacos
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
CN104434852B (zh) * 2013-09-18 2018-11-20 北京韩美药品有限公司 泛昔洛韦直压片及其制备方法
CN112587491B (zh) * 2021-01-03 2022-08-23 迪沙药业集团有限公司 一种泛昔洛韦片组合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671970A1 (fr) * 1991-01-30 1992-07-31 Wellcome Found Comprimes dispersables dans l'eau.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421800C1 (de) * 1984-06-12 1986-04-17 Maschinen und Werkzeugbau Michael Brümmer GmbH, 8804 Dinkelsbühl Elastische Walze zum Behandeln einer thermoplastischen Folie
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
CA2103050A1 (en) 1991-05-15 1992-11-16 Yung-Chi Cheng Determination of prodrugs metabolizable by the liver and therapeutic use thereof
GB9303157D0 (en) * 1993-02-17 1993-03-31 Scotia Holdings Plc Treatment of a group of related disorders
IL111138A (en) 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
JP3702594B2 (ja) * 1997-08-07 2005-10-05 株式会社明電舎 パラメータ調節方法及び装置

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671970A1 (fr) * 1991-01-30 1992-07-31 Wellcome Found Comprimes dispersables dans l'eau.

Also Published As

Publication number Publication date
HUP9901021A3 (en) 2000-08-28
GB9600847D0 (en) 1996-03-20
OA10812A (en) 2003-01-29
TW434016B (en) 2001-05-16
NZ326769A (en) 2000-05-26
BG63488B1 (bg) 2002-03-29
PE35498A1 (es) 1998-08-07
UY24556A1 (es) 2001-08-27
AP1114A (en) 2002-10-18
UY24437A1 (es) 1997-06-06
JP2000503311A (ja) 2000-03-21
IL124913A0 (en) 1999-01-26
BR9706982A (pt) 1999-07-20
AP747A (en) 1999-05-03
TR199800954T2 (xx) 1998-10-21
EG23684A (en) 2007-05-09
ATE220910T1 (de) 2002-08-15
DE69714215T2 (de) 2003-01-23
AP9801298A0 (en) 1998-09-30
CN1208350A (zh) 1999-02-17
CY2390B1 (en) 2004-09-10
CZ287205B6 (en) 2000-10-11
AU1541897A (en) 1997-08-11
AP9700911A0 (en) 1997-01-31
US6765007B1 (en) 2004-07-20
HK1016473A1 (en) 1999-11-05
PL187291B1 (pl) 2004-06-30
BG102638A (en) 1999-07-30
EA199800573A1 (ru) 1999-02-25
SK95698A3 (en) 1999-01-11
NO983259D0 (no) 1998-07-15
CZ225498A3 (cs) 1998-12-16
EP0874632B1 (en) 2002-07-24
ES2180922T3 (es) 2003-02-16
KR19990077229A (ko) 1999-10-25
SK282132B6 (sk) 2001-11-06
NO983259L (no) 1998-07-15
WO1997025990A1 (en) 1997-07-24
DK0874632T3 (da) 2002-11-11
EP0874632A1 (en) 1998-11-04
NO315689B1 (no) 2003-10-13
UA63897C2 (en) 2004-02-16
AR005456A1 (es) 1999-06-23
EA001946B1 (ru) 2001-10-22
JP4711360B2 (ja) 2011-06-29
ZA97310B (en) 1997-10-23
MX9805713A (es) 1998-10-31
AU713090B2 (en) 1999-11-25
HUP9901021A2 (hu) 1999-08-30
DZ2159A1 (fr) 2002-12-01
HU225472B1 (en) 2006-12-28
PL327922A1 (en) 1999-01-04
DE69714215D1 (de) 2002-08-29
PT874632E (pt) 2002-10-31
MY127527A (en) 2006-12-29
JP2009091362A (ja) 2009-04-30
KR100338829B1 (ko) 2002-07-18

Similar Documents

Publication Publication Date Title
AU599925B2 (en) Sustained release compositions
Torrado et al. Effect of different excipients on the tableting of coated particles
SK81793A3 (en) Water-dispersible tablets
CN1151778C (zh) 含有恩他卡朋和硝替卡朋以及交联纤维素衍生物的药物组合物
SK109899A3 (en) The compositions containing oxacarbazepine, oxacarbazepine film-coated tablets and process for the production of sid formulations
CN106389360A (zh) 盐酸达泊西汀直压片及其制备方法
CN1132582C (zh) 高含量泛西洛维片剂
CN1053570C (zh) 哌啶子基链烷醇的药用组合物-减充血剂复方的制备方法
JP2009091362A6 (ja) 高含量ファムシクロビル錠剤
CN101518518A (zh) 烟酸辛伐他汀缓释制剂及其制备方法
NZ279368A (en) Modified-release metronidazole (a nitroimidazole) compositions
US20080095846A1 (en) Pharmaceutical compositions of antihistamine and decongestant
CA1336687C (en) Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
Weon et al. Optimization study on the formulation of roxithromycin dispersible tablet using experimental design
CN114917195B (zh) 一种吡拉西坦片剂及其制备方法
CA2240462C (en) High-content famciclovir tablets
HRP20030259A2 (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
CZ20031589A3 (cs) Farmaceutický prostředek s obsahem gepironu
CN1562249A (zh) 金刚藤分散片及其制备方法
JPH06227995A (ja) 安定化された固型製剤
AU731964B2 (en) Pharmaceutical composition of fenofibrate with high biological availability and method for preparing same
CN1583053A (zh) 止血宝分散片及其制备方法
WO1998003158A2 (de) Ephedringranulat mit hohem wirkstoffgehalt

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: BELLSOS INTELLECTUAL PROPERTY CO., LTD.

Free format text: FORMER OWNER: SMITHKLINE BEECHAM PLC

Effective date: 20010831

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20010831

Address after: Bermuda Hamilton

Applicant after: Novartis Int Pharm Ltd.

Address before: British Meader Sykes

Applicant before: Smihkline Beecham PLC

C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term

Granted publication date: 20031231

EXPY Termination of patent right or utility model